Difference between revisions of "LncRNAWiki:M"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''MAFA-AS1'' |MAFA-AS1 |RP11-909N17.3, TCONSN/A00014882 |M...")
 
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 +
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 +
Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] '''M''' [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']]
 +
</div>
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
Line 5: Line 8:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''MAFA-AS1''
 
|''MAFA-AS1''
 
|[[MAFA-AS1]]
 
|[[MAFA-AS1]]
−
|RP11-909N17.3, TCONSN/A00014882
+
|"RP11-909N17.3, TCONSN/A00014882"
 
|MAFA antisense RNA 1
 
|MAFA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MAFG-AS1''
 
|''MAFG-AS1''
Line 15: Line 20:
 
|N/A
 
|N/A
 
|MAFG antisense RNA 1 (head to head)
 
|MAFG antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MAFTRR''
 
|''MAFTRR''
Line 20: Line 26:
 
|linc-MAF-4
 
|linc-MAF-4
 
|MAF transcriptional regulator RNA
 
|MAF transcriptional regulator RNA
 +
|_
 
|-
 
|-
 
|''MAGEA8-AS1''
 
|''MAGEA8-AS1''
Line 25: Line 32:
 
|RP5-869M20.2
 
|RP5-869M20.2
 
|MAGEA8 antisense RNA 1 (head to head)
 
|MAGEA8 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MALAT1''
 
|''MALAT1''
 
|[[ENST00000534336.1]]
 
|[[ENST00000534336.1]]
−
|HCN, hepcarcin, LINC00047, long intergenic non-protein coding RNA 47, MALAT-1, mascRNA, metastasis associated in lung adenocarcinoma transcript 1, NCRNA00047, NEAT2, non-protein coding RNA 47, nuclear enriched abundant transcript 2, nuclear paraspeckle assembly transcript 2 (non-protein coding), PRO1073, ENSG00000251562
+
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
 +
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
 
|-
 
|-
 
|''MAPKAPK5-AS1''
 
|''MAPKAPK5-AS1''
Line 35: Line 44:
 
|FLJ39616
 
|FLJ39616
 
|MAPKAPK5 antisense RNA 1
 
|MAPKAPK5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''mascRNA''
 
|''mascRNA''
Line 40: Line 50:
 
|Malat1
 
|Malat1
 
|mascRNA (MALAT1-associated small cytoplasmic RNA)
 
|mascRNA (MALAT1-associated small cytoplasmic RNA)
 +
|_
 
|-
 
|-
 
|''MCM3AP-AS1''
 
|''MCM3AP-AS1''
 
|[[MCM3AP-AS1]]
 
|[[MCM3AP-AS1]]
−
|FLJ10508, NCRNA00031
+
|"FLJ10508, NCRNA00031"
 
|MCM3AP antisense RNA 1
 
|MCM3AP antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MDC1-AS1''
 
|''MDC1-AS1''
Line 50: Line 62:
 
|MDC1-AS
 
|MDC1-AS
 
|MDC1 antisense RNA 1
 
|MDC1 antisense RNA 1
 +
|bladder cancer
 
|-
 
|-
 
|''MEF2C-AS1''
 
|''MEF2C-AS1''
Line 55: Line 68:
 
|N/A
 
|N/A
 
|MEF2C antisense RNA 1
 
|MEF2C antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MEG3''
 
|''MEG3''
 
|[[NONHSAT039745]]
 
|[[NONHSAT039745]]
−
|Gtl2, ENSG00000214548
+
|"Gtl2, ENSG00000214548"
 
|maternally expressed 3 (non-protein coding)
 
|maternally expressed 3 (non-protein coding)
 +
|bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
 
|-
 
|-
 
|''MEG8''
 
|''MEG8''
 
|[[ENST00000553584.1]]
 
|[[ENST00000553584.1]]
−
|Bsr, Imprinted RNA near Meg3/Gtl2, Irm, LINC00024, long intergenic non-protein coding RNA 24, NCRNA00024, non-protein coding RNA 24, Rian, RNA Imprinted and Accumulated in Nucleus, ENSG00000258399
+
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
 
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
 
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
 +
|Prader-Willi/Angelman syndrome
 
|-
 
|-
 
|''MEG9''
 
|''MEG9''
−
|[[ENST00000553584.1]],[[
+
|[[ENST00000553584.1]]
 
|LINC00584
 
|LINC00584
 
|maternally expressed 9 (non-protein coding)
 
|maternally expressed 9 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''MESTIT1''
 
|''MESTIT1''
 
|[[MESTIT1]]
 
|[[MESTIT1]]
−
|NCRNA00040, MEST-AS1
+
|"NCRNA00040, MEST-AS1"
−
|MEST intronic transcript 1, antisense RNA
+
|"MEST intronic transcript 1, antisense RNA"
 +
|_
 
|-
 
|-
 
|''MGAT3-AS1''
 
|''MGAT3-AS1''
Line 80: Line 98:
 
|TapSAKI
 
|TapSAKI
 
|MGAT3 antisense RNA 1
 
|MGAT3 antisense RNA 1
 +
|acute kidney injury
 
|-
 
|-
 
|''MHRT''
 
|''MHRT''
Line 85: Line 104:
 
|Myheart
 
|Myheart
 
|myosin heavy chain-associated RNA transcript
 
|myosin heavy chain-associated RNA transcript
 +
|heart pathological hypertrophy
 
|-
 
|-
 
|''MIAT''
 
|''MIAT''
 
|[[lnc-CRYBA4-2:1]]
 
|[[lnc-CRYBA4-2:1]]
−
|FLJ25967, gomafu, LINC00066, lncRNA-MIAT, long intergenic non-protein coding RNA 66, NCRNA00066, non-protein coding RNA 66, Rncr2
+
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
 
|myocardial infarction associated transcript (non-protein coding)
 
|myocardial infarction associated transcript (non-protein coding)
 +
|myocardial infarction
 
|-
 
|-
 
|''MIF-AS1''
 
|''MIF-AS1''
Line 95: Line 116:
 
|LOC284889
 
|LOC284889
 
|MIF antisense RNA 1
 
|MIF antisense RNA 1
 +
|malaria susceptibility
 
|-
 
|-
 
|''MIMT1''
 
|''MIMT1''
 
|[[MIMT1]]
 
|[[MIMT1]]
−
|MIM1, NCRNA00067, LINC00067
+
|"MIM1, NCRNA00067, LINC00067"
 
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
 
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''MINCR''
 
|''MINCR''
Line 105: Line 128:
 
|TCONSN/A00015189
 
|TCONSN/A00015189
 
|MYC-induced long noncoding RNA
 
|MYC-induced long noncoding RNA
 +
|Burkitt lymphoma
 
|-
 
|-
 
|''MIR100HG''
 
|''MIR100HG''
 
|[[ENST00000531381.1]]
 
|[[ENST00000531381.1]]
−
|AGD1, lncRNA-N2
+
|"AGD1, lncRNA-N2"
 
|mir-100-let-7a-2 cluster host gene
 
|mir-100-let-7a-2 cluster host gene
 +
|myeloid leukemia
 
|-
 
|-
 
|''MIR137HG''
 
|''MIR137HG''
Line 115: Line 140:
 
|N/A
 
|N/A
 
|MIR137 host gene
 
|MIR137 host gene
 +
|schizophrenia
 
|-
 
|-
 
|''MIR155HG''
 
|''MIR155HG''
 
|[[NONHSAT081499]]
 
|[[NONHSAT081499]]
−
|BIC, NCRNA00172
+
|"BIC, NCRNA00172"
 
|MIR155 host gene
 
|MIR155 host gene
 +
|chronic lymphocytic leukemia
 
|-
 
|-
 
|''MIR17HG''
 
|''MIR17HG''
 
|[[MIR17HG]]
 
|[[MIR17HG]]
−
|FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048
+
|"FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048"
 
|miR-17-92a-1 cluster host gene
 
|miR-17-92a-1 cluster host gene
 +
|lymphoma, syndromic developmental defect
 
|-
 
|-
 
|''MIR181A2HG''
 
|''MIR181A2HG''
Line 130: Line 158:
 
|N/A
 
|N/A
 
|MIR181A2 host gene
 
|MIR181A2 host gene
 +
|_
 
|-
 
|-
 
|''MIR210HG''
 
|''MIR210HG''
Line 135: Line 164:
 
|N/A
 
|N/A
 
|MIR210 host gene
 
|MIR210 host gene
 +
|inflammatory renal epithelial injury
 
|-
 
|-
 
|''MIR222HG''
 
|''MIR222HG''
Line 140: Line 170:
 
|Lnc-Ang362
 
|Lnc-Ang362
 
|MIR222 host gene
 
|MIR222 host gene
 +
|Ang II-associated cardiovascular disease
 
|-
 
|-
 
|''MIR22HG''
 
|''MIR22HG''
 
|[[ENST00000574306.1]]
 
|[[ENST00000574306.1]]
−
|MGC14376, DKFZp686O06159, LOC554202
+
|"MGC14376, DKFZp686O06159, LOC554202"
 
|MIR22 host gene
 
|MIR22 host gene
 +
|_
 
|-
 
|-
 
|''MIR34AHG''
 
|''MIR34AHG''
Line 150: Line 182:
 
|N/A
 
|N/A
 
|MIR34A host gene
 
|MIR34A host gene
 +
|_
 
|-
 
|-
 
|''MIR4435-2HG''
 
|''MIR4435-2HG''
 
|[[MIR4435-2HG]]
 
|[[MIR4435-2HG]]
−
|LINC00978, AGD2, AK001796
+
|"LINC00978, AGD2, AK001796"
 
|MIR4435-2 host gene
 
|MIR4435-2 host gene
 +
|_
 
|-
 
|-
 
|''MIR503HG''
 
|''MIR503HG''
 
|[[ENST00000414769.1]]
 
|[[ENST00000414769.1]]
−
|MGC16121, H19X
+
|"MGC16121, H19X"
 
|MIR503 host gene
 
|MIR503 host gene
 +
|choriocarcinoma
 
|-
 
|-
 
|''MIR600HG''
 
|''MIR600HG''
 
|[[MIR600HG]]
 
|[[MIR600HG]]
−
|GL012, FLJ22161
+
|"GL012, FLJ22161"
 
|MIR600 host gene
 
|MIR600 host gene
 +
|_
 
|-
 
|-
 
|''MIR663AHG''
 
|''MIR663AHG''
Line 170: Line 206:
 
|RP3-410C9.1
 
|RP3-410C9.1
 
|MIR663A host gene
 
|MIR663A host gene
 +
|_
 
|-
 
|-
 
|''MIR7-3HG''
 
|''MIR7-3HG''
 
|[[MIR7-3HG]]
 
|[[MIR7-3HG]]
−
|PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2
+
|"PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2"
 
|MIR7-3 host gene
 
|MIR7-3 host gene
 +
|_
 
|-
 
|-
 
|''MIR99AHG''
 
|''MIR99AHG''
Line 180: Line 218:
 
|MONC
 
|MONC
 
|mir-99a-let-7c cluster host gene
 
|mir-99a-let-7c cluster host gene
 +
|myeloid leukemia
 
|-
 
|-
 
|''MIRLET7BHG''
 
|''MIRLET7BHG''
Line 185: Line 224:
 
|linc-Ppara
 
|linc-Ppara
 
|MIRLET7B host gene
 
|MIRLET7B host gene
 +
|asbestos exposure-related lung cancer
 
|-
 
|-
 
|''MIRLET7DHG''
 
|''MIRLET7DHG''
Line 190: Line 230:
 
|N/A
 
|N/A
 
|MIRLET7D host gene
 
|MIRLET7D host gene
 +
|_
 
|-
 
|-
 
|''MKRN3-AS1''
 
|''MKRN3-AS1''
 
|[[MKRN3-AS1]]
 
|[[MKRN3-AS1]]
−
|FNZ127, NCRNA00009, ZNF127-AS
+
|"FNZ127, NCRNA00009, ZNF127-AS"
 
|MKRN3 antisense RNA 1
 
|MKRN3 antisense RNA 1
 +
|Prader-Willi syndrome ;Angelman syndromes
 
|-
 
|-
 
|''MLK7-AS1''
 
|''MLK7-AS1''
Line 200: Line 242:
 
|N/A
 
|N/A
 
|MLK7 antisense RNA 1
 
|MLK7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MLLT4-AS1''
 
|''MLLT4-AS1''
 
|[[MLLT4-AS1]]
 
|[[MLLT4-AS1]]
−
|HGC6.4, dJ431P23.3
+
|"HGC6.4, dJ431P23.3"
 
|MLLT4 antisense RNA 1 (head to head)
 
|MLLT4 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MORF4L2-AS1''
 
|''MORF4L2-AS1''
Line 210: Line 254:
 
|N/A
 
|N/A
 
|MORF4L2 antisense RNA 1
 
|MORF4L2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MT-LIPCAR''
 
|''MT-LIPCAR''
 
|[[MT-LIPCAR]]
 
|[[MT-LIPCAR]]
−
|uc022bqs.1, LIPCAR
+
|"uc022bqs.1, LIPCAR"
 
|mitochondrially encoded long non-coding cardiac associated RNA
 
|mitochondrially encoded long non-coding cardiac associated RNA
 +
|heart failure
 
|-
 
|-
 
|''MYCNOS''
 
|''MYCNOS''
 
|[[MYCNOS]]
 
|[[MYCNOS]]
−
|NCYM, N-CYM, MYCN-AS1
+
|"NCYM, N-CYM, MYCN-AS1"
 
|MYCN opposite strand
 
|MYCN opposite strand
 +
|neuroblastoma
 
|-
 
|-
 
|''MYCNUT''
 
|''MYCNUT''
Line 225: Line 272:
 
|lncUSMycN
 
|lncUSMycN
 
|MYCN upstream transcript (non-protein coding)
 
|MYCN upstream transcript (non-protein coding)
 +
|neuroblastoma
 +
|-
 +
|''MAGI2-AS3''
 +
|[[MAGI2-AS3]]
 +
|ENST00000414797
 +
|MAGI2 antisense RNA 3
 +
|early-onset preeclampsia
 +
|-
 +
|''MAPT-AS1''
 +
|[[MAPT-AS1]]
 +
|N/A
 +
|MAPT antisense RNA 1
 +
|Parkinson's Disease
 +
|-
 +
|''MDS2''
 +
|[[MDS2]]
 +
|N/A
 +
|myelodysplastic syndrome 2 translocation associated
 +
|myelodysplastic syndrome
 +
|-
 +
|''MEF2C-AS2''
 +
|[[MEF2C-AS2]]
 +
|CTC-467M3.1
 +
|MEF2C antisense RNA 2
 +
|B cell lymphoma
 +
|-
 +
|''MELTF-AS1''
 +
|[[MELTF-AS1]]
 +
|MFI2-AS1
 +
|MELTF antisense RNA 1
 +
|osteosarcoma
 +
|-
 +
|''MHENCR''
 +
|[[MHENCR]]
 +
|N/A
 +
|melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489
 +
|Melanoma
 +
|-
 +
|''MIR200CHG''
 +
|[[MIR200CHG]]
 +
|U47924.27
 +
|MIR200C and MIR141 host gene
 +
|Melanoma tumorigenesis
 +
|-
 +
|''MIR2052HG''
 +
|[[MIR2052HG]]
 +
|N/A
 +
|MIR2052 host gene
 +
|breast cancer
 +
|-
 +
|''MIR3936HG''
 +
|[[MIR3936HG]]
 +
|LOC553103, SLC22A5-AS1
 +
|MIR3936 host gene
 +
|nasopharyngeal carcinoma, gastric cancer
 +
|-
 +
|''MIR4422HG''
 +
|[[MIR4422HG]]
 +
|RP11-101C11.1
 +
|MIR4422 host gene
 +
|B cell lymphoma
 +
|-
 +
|''MIR4713HG''
 +
|[[MIR4713HG]]
 +
|RP11-108K3.1
 +
|MIR4713 host gene
 +
|Colorectal adenocarcinoma
 +
|-
 +
|''MMP2-AS1''
 +
|[[MMP2-AS1]]
 +
|ENST00000569037
 +
|MMP2 antisense RNA 1
 +
|early-onset preeclampsia
 +
|-
 +
|''MNX1-AS1''
 +
|[[MNX1-AS1]]
 +
|CCAT5, LOC645249
 +
|MNX1 antisense RNA 1 (head to head)
 +
|Ovarian Cancer
 +
|-
 +
|''MNX1-AS2''
 +
|[[MNX1-AS2]]
 +
|ENST00000429228
 +
|MNX1 antisense RNA 2
 +
|early-onset preeclampsia
 +
|''MAP3K20-AS1''
 +
|[[MAP3K20-AS1]]
 +
|N/A
 +
|MAP3K20 antisense RNA 1
 +
|_
 +
|-
 +
|''MYOSLID''
 +
|[[MYOSLID]]
 +
|N/A
 +
|myocardin-induced smooth muscle lncRNA, inducer of differentiation
 +
|_
 
|}
 
|}

Latest revision as of 12:39, 29 June 2017

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z BACK

Name Transcript ID Alias Description Disease
MAFA-AS1 MAFA-AS1 "RP11-909N17.3, TCONSN/A00014882" MAFA antisense RNA 1 _
MAFG-AS1 MAFG-AS1 N/A MAFG antisense RNA 1 (head to head) _
MAFTRR MAFTRR linc-MAF-4 MAF transcriptional regulator RNA _
MAGEA8-AS1 MAGEA8-AS1 RP5-869M20.2 MAGEA8 antisense RNA 1 (head to head) _
MALAT1 ENST00000534336.1 "HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562" metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
MAPKAPK5-AS1 MAPKAPK5-AS1 FLJ39616 MAPKAPK5 antisense RNA 1 _
mascRNA lnc-SCYL1-1:5 Malat1 mascRNA (MALAT1-associated small cytoplasmic RNA) _
MCM3AP-AS1 MCM3AP-AS1 "FLJ10508, NCRNA00031" MCM3AP antisense RNA 1 _
MDC1-AS1 MDC1-AS1 MDC1-AS MDC1 antisense RNA 1 bladder cancer
MEF2C-AS1 MEF2C-AS1 N/A MEF2C antisense RNA 1 _
MEG3 NONHSAT039745 "Gtl2, ENSG00000214548" maternally expressed 3 (non-protein coding) bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
MEG8 ENST00000553584.1 "Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399" Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 Prader-Willi/Angelman syndrome
MEG9 ENST00000553584.1 LINC00584 maternally expressed 9 (non-protein coding) _
MESTIT1 MESTIT1 "NCRNA00040, MEST-AS1" "MEST intronic transcript 1, antisense RNA" _
MGAT3-AS1 MGAT3-AS1 TapSAKI MGAT3 antisense RNA 1 acute kidney injury
MHRT MHRT Myheart myosin heavy chain-associated RNA transcript heart pathological hypertrophy
MIAT lnc-CRYBA4-2:1 "FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2" myocardial infarction associated transcript (non-protein coding) myocardial infarction
MIF-AS1 MIF-AS1 LOC284889 MIF antisense RNA 1 malaria susceptibility
MIMT1 MIMT1 "MIM1, NCRNA00067, LINC00067" MER1 repeat containing imprinted transcript 1 (non-protein coding) _
MINCR ENST00000517411.1 TCONSN/A00015189 MYC-induced long noncoding RNA Burkitt lymphoma
MIR100HG ENST00000531381.1 "AGD1, lncRNA-N2" mir-100-let-7a-2 cluster host gene myeloid leukemia
MIR137HG MIR137HG N/A MIR137 host gene schizophrenia
MIR155HG NONHSAT081499 "BIC, NCRNA00172" MIR155 host gene chronic lymphocytic leukemia
MIR17HG MIR17HG "FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048" miR-17-92a-1 cluster host gene lymphoma, syndromic developmental defect
MIR181A2HG MIR181A2HG N/A MIR181A2 host gene _
MIR210HG MIR210HG N/A MIR210 host gene inflammatory renal epithelial injury
MIR222HG ENST00000602507.1 Lnc-Ang362 MIR222 host gene Ang II-associated cardiovascular disease
MIR22HG ENST00000574306.1 "MGC14376, DKFZp686O06159, LOC554202" MIR22 host gene _
MIR34AHG MIR34AHG N/A MIR34A host gene _
MIR4435-2HG MIR4435-2HG "LINC00978, AGD2, AK001796" MIR4435-2 host gene _
MIR503HG ENST00000414769.1 "MGC16121, H19X" MIR503 host gene choriocarcinoma
MIR600HG MIR600HG "GL012, FLJ22161" MIR600 host gene _
MIR663AHG MIR663AHG RP3-410C9.1 MIR663A host gene _
MIR7-3HG MIR7-3HG "PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2" MIR7-3 host gene _
MIR99AHG ENST00000602580.1 MONC mir-99a-let-7c cluster host gene myeloid leukemia
MIRLET7BHG MIRLET7BHG linc-Ppara MIRLET7B host gene asbestos exposure-related lung cancer
MIRLET7DHG MIRLET7DHG N/A MIRLET7D host gene _
MKRN3-AS1 MKRN3-AS1 "FNZ127, NCRNA00009, ZNF127-AS" MKRN3 antisense RNA 1 Prader-Willi syndrome ;Angelman syndromes
MLK7-AS1 MLK7-AS1 N/A MLK7 antisense RNA 1 _
MLLT4-AS1 MLLT4-AS1 "HGC6.4, dJ431P23.3" MLLT4 antisense RNA 1 (head to head) _
MORF4L2-AS1 MORF4L2-AS1 N/A MORF4L2 antisense RNA 1 _
MT-LIPCAR MT-LIPCAR "uc022bqs.1, LIPCAR" mitochondrially encoded long non-coding cardiac associated RNA heart failure
MYCNOS MYCNOS "NCYM, N-CYM, MYCN-AS1" MYCN opposite strand neuroblastoma
MYCNUT ENST00000433810.1 lncUSMycN MYCN upstream transcript (non-protein coding) neuroblastoma
MAGI2-AS3 MAGI2-AS3 ENST00000414797 MAGI2 antisense RNA 3 early-onset preeclampsia
MAPT-AS1 MAPT-AS1 N/A MAPT antisense RNA 1 Parkinson's Disease
MDS2 MDS2 N/A myelodysplastic syndrome 2 translocation associated myelodysplastic syndrome
MEF2C-AS2 MEF2C-AS2 CTC-467M3.1 MEF2C antisense RNA 2 B cell lymphoma
MELTF-AS1 MELTF-AS1 MFI2-AS1 MELTF antisense RNA 1 osteosarcoma
MHENCR MHENCR N/A melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 Melanoma
MIR200CHG MIR200CHG U47924.27 MIR200C and MIR141 host gene Melanoma tumorigenesis
MIR2052HG MIR2052HG N/A MIR2052 host gene breast cancer
MIR3936HG MIR3936HG LOC553103, SLC22A5-AS1 MIR3936 host gene nasopharyngeal carcinoma, gastric cancer
MIR4422HG MIR4422HG RP11-101C11.1 MIR4422 host gene B cell lymphoma
MIR4713HG MIR4713HG RP11-108K3.1 MIR4713 host gene Colorectal adenocarcinoma
MMP2-AS1 MMP2-AS1 ENST00000569037 MMP2 antisense RNA 1 early-onset preeclampsia
MNX1-AS1 MNX1-AS1 CCAT5, LOC645249 MNX1 antisense RNA 1 (head to head) Ovarian Cancer
MNX1-AS2 MNX1-AS2 ENST00000429228 MNX1 antisense RNA 2 early-onset preeclampsia MAP3K20-AS1 MAP3K20-AS1 N/A MAP3K20 antisense RNA 1 _
MYOSLID MYOSLID N/A myocardin-induced smooth muscle lncRNA, inducer of differentiation _
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:M&oldid=1273175"